Table 2.
Prognostic factors for adverse events due to COVID-19 in IBD patients
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Men | 1.40 | 0.64–3.09 | 0.402 | 1.49 | 0.58–3.83 | 0.410 |
| Age in years | 1.05 | 1.02–1.08 | 0.001 | 1.04 | 1.00–1.08 | 0.038 |
| BMI (kg/m2) | 1.12 | 1.02–1.21 | 0.012 | 1.00 | 0.89–1.12 | 0.971 |
| DM | 11.42 | 1.15–113.6 | 0.038 | 6.16 | 0.51–75.08 | 0.154 |
| Hypertension | 3.40 | 1.33–8.66 | 0.010 | 1.36 | 0.36–5.19 | 0.654 |
| anti-TNF | 0.45 | 0.21–0.98 | 0.043 | 0.40 | 0.16–0.99 | 0.049 |
| Fever | 3.34 | 1.10–10.17 | 0.034 | 3.11 | 0.88–10.97 | 0.077 |
| Dyspnea | 7.92 | 2.63–23.87 | <0.001 | 7.36 | 1.84–29.46 | 0.005 |
CI, confidence intervals; DM, diabetes mellitus; OR, odds ratio.